Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dum

Showing results (11-20 of 92) with videos related to

Pageof 10
Sort By:
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 25, 2021
Overexpression of the TRIM24 E3 Ubiquitin Ligase is Linked to Genetic Instability and Predicts Unfavorable Prognosis in Prostate CancerDoris Höflmayer, Christoph Fraune, Claudia Hube-Magg, et al.
Urologic Oncology|November 24, 2019
8p deletions in renal cell carcinoma are associated with unfavorable tumor features and poor overall survivalTill Eichenauer, David C Bannenberg, Martina Kluth, et al.
Virchows Archiv : an International Journal of Pathology|August 11, 2022
FABP1 expression in human tumors: a tissue microarray study on 17,071 tumorsDavid Dum, Ana Ocokoljic, Maximilian Lennartz, et al.
Pathology, Research and Practice|November 9, 2024
PGP9.5 expression in human tumors: A tissue microarray study on 13,920 tumors from 120 different tumor entitiesSekander Scherzai, Maximilian Lennartz, Frank Jacobsen, et al.
BMC Cancer|December 19, 2020
Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancerMorton Freytag, Martina Kluth, Elena Bady, et al.
Human Pathology|May 13, 2022
Large-scale human tissue analysis identifies Uroplakin 1b as a putative diagnostic marker in surgical pathologyViktor Reiswich, Gonca Akdeniz, Maximilian Lennartz, et al.
International Journal of Cancer|March 10, 2020
Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancersAndreas M Luebke, Wiebke Ricken, Martina Kluth, et al.
Oncotarget|March 23, 2019
A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancerTill Eichenauer, Mohammad Hussein, Claudia Hube-Magg, et al.
Disease Markers|January 25, 2020
Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal TissuesSimon Kind, Christina Merenkow, Franziska Büscheck, et al.
Diagnostics (Basel, Switzerland)|December 24, 2021
Large-Scale Tissue Microarray Evaluation Corroborates High Specificity of High-Level Arginase-1 Immunostaining for Hepatocellular CarcinomaMaximilian Lennartz, Eva Gehrig, Sören Weidemann, et al.
Pageof 10

Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 25, 2021
Overexpression of the TRIM24 E3 Ubiquitin Ligase is Linked to Genetic Instability and Predicts Unfavorable Prognosis in Prostate CancerDoris Höflmayer, Christoph Fraune, Claudia Hube-Magg, et al.
Urologic Oncology|November 24, 2019
8p deletions in renal cell carcinoma are associated with unfavorable tumor features and poor overall survivalTill Eichenauer, David C Bannenberg, Martina Kluth, et al.
Virchows Archiv : an International Journal of Pathology|August 11, 2022
FABP1 expression in human tumors: a tissue microarray study on 17,071 tumorsDavid Dum, Ana Ocokoljic, Maximilian Lennartz, et al.
Pathology, Research and Practice|November 9, 2024
PGP9.5 expression in human tumors: A tissue microarray study on 13,920 tumors from 120 different tumor entitiesSekander Scherzai, Maximilian Lennartz, Frank Jacobsen, et al.
BMC Cancer|December 19, 2020
Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancerMorton Freytag, Martina Kluth, Elena Bady, et al.
Human Pathology|May 13, 2022
Large-scale human tissue analysis identifies Uroplakin 1b as a putative diagnostic marker in surgical pathologyViktor Reiswich, Gonca Akdeniz, Maximilian Lennartz, et al.
International Journal of Cancer|March 10, 2020
Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancersAndreas M Luebke, Wiebke Ricken, Martina Kluth, et al.
Oncotarget|March 23, 2019
A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancerTill Eichenauer, Mohammad Hussein, Claudia Hube-Magg, et al.
Disease Markers|January 25, 2020
Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal TissuesSimon Kind, Christina Merenkow, Franziska Büscheck, et al.
Diagnostics (Basel, Switzerland)|December 24, 2021
Large-Scale Tissue Microarray Evaluation Corroborates High Specificity of High-Level Arginase-1 Immunostaining for Hepatocellular CarcinomaMaximilian Lennartz, Eva Gehrig, Sören Weidemann, et al.
Pageof 10